When Hybridomas Die: Recovering Critical Reagents with Antibody Sequencing

2025-09-04T11:49:35-04:00September 4th, 2025|Case Studies|

To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications